Higher co-payments lead to early discontinuation of life-saving therapy for breast ca

[News]

A higher prescription co-payment, especially among older women, is associated with both early discontinuation and incomplete use of adjuvant aromatase inhibitor therapy, a life-saving therapy for women with hormone sensitive early stage breast cancer.

More... (http://www.news-medical.net/news/20101213/Higher-co-payments-lead-to-early-discontinuation-of-life-saving-therapy-for-breast-cancer.aspx)